title: Activation of neuronal defense mechanisms in response to pathogenic factors triggering induction of amyloidosis in Alzheimer's disease.
abstract: We present a new model for etiology of Alzheimer's disease (AD) which postulates early involvement of specialized neuroprotective mechanisms in the pathology of AD. These neuroprotective mechanisms work in concert to regulate metabolic homeostasis in healthy neuronal cells, but contribute to the distinctive cytopathic phenotype of neuronal degeneration in AD. According to this model, two molecular/genetic hallmarks of AD, amyloid-β (Aβ) deposition and tau hyperphosphorylation, are associated with neuronal mechanisms for dissipating thermal energy associated with high levels of protein synthesis in highly temperature-sensitive neuronal cells. Development of effective methods of AD treatment will require a better understanding of how this neuronal defense system is activated in response to cytopathological triggers in sporadic AD. The cause and effect link between synthesis and processing of amyloid-β protein precursor (AβPP) and the AD terminal phenotype of neurofibrillary tangles and neuron loss involve the formation of Aβ peptides that accumulate as oligomers, cannot be controlled by neurons, and are toxic to the surrounding neuronal membranes. We analyze experimental and clinical studies that have investigated the correlation between phosphorylation of some transport proteins and increased synthesis of proteins in neurons. We also review the evidence related to the possibility that protein hyperphosphorylation may be a byproduct of energetic imbalances in AD cells associated with high levels of protein synthesis, and that activation of defense systems, through which energy-rich molecules are eliminated from the site of protein synthesis and are sequestered to the peripheral neuronal areas, may bring about some of the distinctive morphological features of AD.
authors.affiliation: Russian Gerontological Research Clinical Center, Russian Ministry of Health Care, Moscow, Russia Institute of Experimental and Theoretical Biophysics, Russian Academy of Sciences, Pushchino, Moscow Region, Russia.
authors.forename: Alexander V
authors.initials: AV
authors.lastname: Maltsev
authors.affiliation: Allied Innovative Systems, LLC, Hillsborough, NJ, USA.
authors.forename: Rasa
authors.initials: R
authors.lastname: Santockyte
authors.affiliation: Allied Innovative Systems, LLC, Hillsborough, NJ, USA.
authors.forename: Simon
authors.initials: S
authors.lastname: Bystryak
authors.affiliation: Institute of Protein Research, Russian Academy of Sciences, Pushchino, Moscow Region, Russia.
authors.forename: Oxana V
authors.initials: OV
authors.lastname: Galzitskaya
mesh_terms: D000544:Alzheimer Disease / Q000150:complications / Q000209:etiology* / Q000473:pathology*; D000686:Amyloidosis / Q000150:complications*; D000818:Animals; D002352:Carrier Proteins / Q000502:physiology*; D006801:Humans; D008954:Models, Biological; D009474:Neurons / Q000502:physiology*; D010766:Phosphorylation; D037521:Virulence Factors / Q000633:toxicity
chemical_list: D002352:Carrier Proteins; D037521:Virulence Factors
keywords: Alzheimer's disease; amyloid-β protein precursor; amyloidosis; cellular defense factors; hyperphosphorylation; neuron loss; phosphorylation; tau protein